MedPath

Interventional Management of Trigeminal Neuralgia

Not yet recruiting
Conditions
ASA I and II patients with unilateral trigeminal neuralgia
Registration Number
CTRI/2018/01/011494
Lead Sponsor
AIIMS New Delhi
Brief Summary

1.          Slavica Katusic et al.Incidence and clinical features of trigeminal neuralgia. Annals of Neurology.1990; 27: 89-95.

2.          Yoshimasu et al. Ticdolorourex in Rochester Minnesota (1945-1969). Neurology. 1972; 22: 952-956.

3.          Krafft RM - Trigeminal neuralgia. Am FamPhysician. 2008;77: 1291-1296.

4.          Jannetta PJ. Arterialcompression of the trigeminal nerve at the pons in patients with trigeminalneuralgia. J Neurosurg. 1967; 26 :159-62.

5.          Jellish WS,  Benedict W, Owen K, Anderson D, Fluder E, SheaJF. Perioperative and long-term operative outcomes after surgery for trigeminalneuralgia: microvascular decompression vs percutaneous balloon ablation; Headand face medicine. 2008; 4: 11-18.

6.          Hakanson S. Trigeminalneuralgia treated by the injection of glycerol into the trigeminal cistern.Neurosurgery. 1981; 9 : 638-646.

7.          Sweet WH, Wepsic JG.Controlled thermocoagulation of trigeminal ganglion and rootlets fordifferential destruction of pain fibres. Part I:trigeminal neuralgia. Jneurosurg. 1974;39:143-156.

8.          Slaviket al . Idiopathic trigeminal neuralgia- radiofrequency rhizotomy of ganglionGasseria: Acta chir lugosl. 2004;51:31-38.

9.          Mullan S, Lichtor T .Percutaneous microcompression of the trigeminal ganglion for trigeminalneuralgia. J Neurosurg. 1983 ; 59 : 1007-1012.

10.       John D Loeser. CranialNeuralgias.  In: John D. Loeser, Stephen H. Butler,  C. Richard Chapman,  and Dennis .C. Turk, editors. Bonica’s  Management of pain. Lippincott Williams & Wilkins. 2001:855-864.

11.       Deon F Louw, Kim J Burchiel.Surgical treatment of trigeminal neuralgia. In:John D. Loeser, Stephen H. Butler, C. Richard Chapman, and Dennis .C. Turk,editors. Bonica’s Management of pain. Lippincott Williams & Wilkins. 2001: 2038-2047.

12.       Devor M, Amir R, Rappaport ZH.Pathophysiology of trigeminal neuralgia. Clin Journal of Pain. 2002 ; 18:4-13.

13.       Burchiel K. J., Moore K. L.Neurosurgical treatment of pain : trigeminal neuralgia. Outcomes inneurological and neurosurgical disorders. Cambridge University Press, 1998;507-532.

14.       Tew JM, Taha JM. Therapeutic Decisions in FacialPain. Clinical Neurosurgery. 2000; 46:410-431.

15.       Lee FC. Trigeminal neuralgia.J Med Assoc Georgia. 1937; 26: 431-436.

16.       Taarnhoj P .Decompression ofthe trigeminal root and the posterior part of the ganglion as treatment in trigeminalneuralgia. Preliminary communication. J Neurosurg 1952; 9:288-290.

17.       Shelden CH, Pundenz RH. Compression rather thandecompression for trigeminal neuralgia.J Neurosurg. 1955; 12: 123-126.

18.       Omeiset al. Percutaneous balloon compression for the treatment of recurrenttrigeminal neuralgia. Stereotctic and Functional neurosurgery. 2008;86:259-265.

19.       Park SS et al. Percutaneousballoon compression of the trigeminal ganglion for the treatment of Idiopathictrigeminal neuralgia: Experience in 50 patients. J Korean Neurosurg . 2008;43:186-189.

20.       Liu HB et al . Percutaneousmicroballoon compression for trigeminal neuralgia. Chin Med J. 2007; 120:228-230.

21.       Skirving DJ, Dan NG. A 20-yearreview of percutaneous balloon compression of the trigeminal ganglion. J Neurosurg.2001; 94: 913-917.

22.       Ahn KS, Lee MK, Hwang SH, LeeJE, Cho CW, Kim DJ. Percutaneous Balloon Compression of Trigeminal Ganglion forthe treatment of idiopathic Trigeminal Neuralgia. J Korean Neurosurg . 2004; 36: 213-217.

23.       Benoit B G, Baeesa S S . PercutaneousBalloon Compression of  the GasserianGanglion for Trigeminal Neuralgia. Pan Arab Journals; 3:1-5.

24.       Brown JA , Preul MC.Trigeminal depressor response during percutaneous microcompression of thetrigeminal ganglion for trigeminal neuralgia . Neurosurgery. 1988; 23 :745-748.

25.       Brown JA.Trigeminalneuralgia-Percutaneous trigeminal nerve compression. Neurosurgical PainManagement. 2004;3: 214-218.

26.       Lobata RD,  Rivas JJ, Sarabia R, Lamas E . Percutaneousmicrocompression of the gasserian ganglion for trigeminal neuralgia. JNeurosurg . 1990 ; 72 : 546-553.

27.       Urculo E, Alfaro R, ArrazolaM, Astudillo E, Rejas G . Trochlear nerve palsy after repeated percutaneousballoon compression for recurrent trigeminal neuralgia : Case report andpathologenic considerations. Neurosurgery. 2004; 54: 505-509.

28.       NugentGR. Percutaneous techniques for trigeminal neuralgia. Operative Neurosurgery.2000:  1615–1633.

29.       MeglioM and Cioni B. Percutaneous procedures for trigeminal neuralgia:microcompression versus radiofrequency thermocoagulation. Pain. 1989;38:9-16.

30.       Burton M. Onoforio. Radiofrequency percutaneous Gasserian ganglion lesions.Results in 140 patients with trigeminal pain. J. Neurosurg. 1975;42:132-39.

31.       [Erdine S](http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Erdine%20S%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus), Ozyalcin N S, Cimen A . Comparison ofpulsed radiofrequency with conventional radio frequency in the treatment ofidiopathic trigeminal neuralgia. Eur J Pain.2007 Apr;11:309-313.

32.       BidkarPrasanna Udupi ,Rajendra S Chouhan,Dash,Hari H.Comparative evaluation ofpercutataneous retrogasserian glycerol rhizolysis and radiofrequencythermocoagulation techniques in the management of trigeminal neuralgia.Neurosurgery.Feb 2012; 70:407-413.

33.       MathewT Bender ,Gustavo Pradilla, Carol James.Glycerol rhizotomy and Radiofrequencythermocoagulation for trigeminal neuralgia in multiple sclerosis. JNeurosurgery. 2013 Feb; 118:329-336.

34.       T.P.Jorns,J. M.Zakrzewska.Evidence-based approach to the medical management of trigeminalneuralgia.British journal of neurosurgery.2007June;21:253-261.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria
  • •Thirty adult patients of either sex diagnosed to have Classical trigeminal neuralgia will be recruited for this study.
  • Classic TN will be diagnosed according to the International Classification of Headache Disorders-II (2004) Classical TN of more than six months’ duration Pain rating (during the attack) of at least six on a Visual analogue scale (VAS/NRS) No satisfactory pain relief with medical treatment for more than three months; and/or intolerable side effects using oral medications.
Exclusion Criteria
  • Patient’s refusal to involve in the study 2.
  • History of allergy to drugs used in the procedures 3.
  • Coagulopathy 4.
  • Morbid obesity.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Multi-dimensional outcomes as recommended by IMMPACT (Initiative on methods, measurement, and pain assessment in clinical trials)Immediate post operative period | Day 7 | Then every month till 1 year
The following domains were assessedImmediate post operative period | Day 7 | Then every month till 1 year
Pain: by 11point (0-10) NRSImmediate post operative period | Day 7 | Then every month till 1 year
Emotional functioning: by Beck Depression InventoryImmediate post operative period | Day 7 | Then every month till 1 year
Global improvement: by Patient Global Impression of changeImmediate post operative period | Day 7 | Then every month till 1 year
Physical functioning: by Brief Pain Inventory-Facial scaleImmediate post operative period | Day 7 | Then every month till 1 year
Secondary Outcome Measures
NameTimeMethod
Health related quality of life would be measured by EQ-5D-3L (paper version) questionnaireSpontaneous reporting of symptoms and adverse events with open ended prompts with each visit

Trial Locations

Locations (1)

AIIMS New Delhi

🇮🇳

South, DELHI, India

AIIMS New Delhi
🇮🇳South, DELHI, India
Dr Virender Kumar Mohan
Principal investigator
9868397803
dr_vkmohan@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.